Neuroblastoma is a pediatric solid cancer of heterogeneous clinical behavior. The unique
features of this type of cancer frequently hamper the process of determining clinical …

High‐precision tumor targeting with conventional therapeutics is based on the concept of the
ideal drug as a “magic bullet”; this became possible after techniques were developed for …

The targeted delivery of radionuclides to tumours holds great promise for diagnosis and
treatment of malignant neoplasms. The development of scaffold proteins has significantly …

The ribonuclease barnase (12 kDa) and its inhibitor barstar (10 kDa) form a very tight
complex in which all N and C termini are accessible for fusion. Here we exploit this system to …

Nanoparticles with biocomputing capabilities could potentially be used to create
sophisticated robotic devices with a variety of biomedical applications, including intelligent …

Antibody-photosensitizer chemical conjugates are used successfully to kill cancer cells in
photodynamic therapy. However, chemical conjugation of photosensitizers presents several …

The rapid elimination of nanoparticles from the bloodstream by the mononuclear phagocyte
system limits the activity of many nanoparticle formulations. Here, we show that inducing a …

Safe application of nanoparticles in medicine requires full understanding of their
pharmacokinetics including catabolism in the organism. However, information about …

Smart nanomaterials, contrast nanoparticles and drug nanocarriers of advanced targeting
architecture were designed for various biomedical applications. Most of such agents …

Having plasmonic absorption within the biological transparency window, titanium nitride
(TiN) nanoparticles (NPs) can potentially outperform gold counterparts in phototheranostic …